Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 5/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.72 |
| ▸ | TTR | P02766 | 4/20 | 0.72 |
| ▸ | NQO2 | P16083 | 4/20 | 0.70 |
| ▸ | ESR1 | P03372 | 3/20 | 0.70 |
| ▸ | ABL1 | P00519 | 3/20 | 0.70 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.70 |
| ▸ | BCR | P11274 | 3/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.70 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.70 |
| ▸ | AHR | P35869 | 2/20 | 0.70 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.70 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.70 |
| ▸ | TUBB | P07437 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resveratrol 4'-Methyl Ether SCHEMBL4732963 | 1.00 | PTGS2 (1.00) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| Resveratrol 4'-Methyl Ether SCHEMBL563261 | 1.00 | PTGS2 (1.00) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL15026080 | 0.92 | PTGS2 (0.85) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL29652111 | 0.92 | PTGS2 (0.86) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL2516446 | 0.92 | PTGS2 (0.86) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL2516449 | 0.92 | PTGS2 (0.86) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL29662231 | 0.92 | PTGS2 (0.86) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL12307322 | 0.89 | PTGS2 (0.79) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL8396878 | 0.87 | PTGS2 (0.77) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 | |
| SCHEMBL12567384 | 0.87 | PTGS2 (0.77) | PTGS2CYP1A1CYP1B1KDM4EPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2679243-B1 | Co-precipitate of one or more stilbene polyphenols in lamellar anionic solids, it's applications and related preparation method | FIORETTI BERNARD (IT) | 2017-05-24 | — | — | EP | claimed |
| US-20120178704-A1 | PREVENTION AND TREATMENT OF COLON CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2012-07-12 | — | — | US | claimed |
| US-20110256115-A1 | HYDROSOLUBLE [6)O-ALPHA-D-GLCP-(1->]N-6-O-BETA-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS | LIBRAGEN (FR) | 2011-10-20 | — | — | US | claimed |
| EP-2202237-A1 | Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds | Libragen (FR) | 2010-06-30 | — | — | EP | claimed |
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CELANESE EMULSIONS GMBH (DE) | 2008-06-12 | — | — | US | claimed |
| WO-2008070872-A1 | PREVENTION AND TREATMENT OF COLON CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2008-06-12 | — | — | WO | claimed |
| EP-4743071-A2 | DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF | INNOVENE INC. (US) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025015023-A2 | DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF | INNOVENE, INC. (US) | 2025-01-16 | — | — | WO | disclosed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-116515752-B | Use of 3, 5-dihydroxy-4' -methoxystilbene-3-O-beta-D-glucoside for promoting proliferation of DC cells in vitro | 沃森克里克（北京）生物科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| WO-2023150072-A1 | COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER | SINCLAIR DAVID A (US) | 2023-08-10 | — | — | WO | disclosed |
| CN-116515752-A | Use of 3, 5-dihydroxy-4' -methoxystilbene-3-O-beta-D-glucoside for promoting proliferation of DC cells in vitro | 沃森克里克（北京）生物科技有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-11129781-B2 | Agent for hair deforming treatment | KAO CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| US-20050240062-A1 | Structural modification of resveratrol: Sodium resverastatin phosphate | NATIONAL INSTITUTES OF HEALTH | 2005-10-27 | — | — | US | disclosed |
| US-20050136537-A1 | Compositions for manipulating the lifespan and stress response of cells and organisms | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-06-23 | — | — | US | disclosed |
| US-20050096256-A1 | Compositions for manipulating the lifespan and stress response of cells and organisms | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-05-05 | — | — | US | disclosed |
| WO-2005002672-A2 | SIRT1 MODULATORS FOR MANIPULATING CELLS/ORGANISM LIFESPAN/STRESS RESPONSE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-01-13 | — | — | WO | disclosed |
| WO-2005002555-A2 | SIRT1 MODULATORS FOR MANIPULATING CELL/ORGANISM LIFESPAN/STRESS RESPONSE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-01-13 | — | — | WO | disclosed |
| WO-2003086414-A1 | STRUCTURAL MODIFICATION OF RESVERATROL: SODIUM RESVERASTATIN PHOSPHATE | ARIZONA BOARD OF REGENTS (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-2003086414-A1 | STRUCTURAL MODIFICATION OF RESVERATROL: SODIUM RESVERASTATIN PHOSPHATE | ARIZONA BOARD OF REGENTS (US) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110256115-A1 | HYDROSOLUBLE [6)O-ALPHA-D-GLCP-(1->]N-6-O-BETA-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS | UGGT1, UGDH, CYP24A1 | PTGS2 1730/4885CYP1A1 333/4885CYP1B1 578/4885 |
| US-20050240062-A1 | Structural modification of resveratrol: Sodium resverastatin phosphate | PI4KB, HDAC4, PIK3CA | PTGS2 3996/4885CYP1A1 3525/4885CYP1B1 2430/4885 |
| US-20120178704-A1 | PREVENTION AND TREATMENT OF COLON CANCER | APC, SI, NFKBIA | PTGS2 28/4885CYP1A1 1123/4885CYP1B1 1133/4885 |
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CBR3, CBR1, CYP3A4 | PTGS2 3728/4885CYP1A1 5/4885CYP1B1 4/4885 |
| US-20050096256-A1 | Compositions for manipulating the lifespan and stress response of cells and organisms | SIRT1, SIRT2, FOXO3 | PTGS2 2650/4885CYP1A1 4175/4885CYP1B1 4123/4885 |
| US-11129781-B2 | Agent for hair deforming treatment | GRHPR, SLC26A4, COL1A1 | PTGS2 3041/4885CYP1A1 2575/4885CYP1B1 751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.